UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents.
Revenue (Most Recent Fiscal Year) | $12.18M |
Net Income (Most Recent Fiscal Year) | $3.25M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | 14.34 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 3.40 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.22 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 11.02 |
Pre-Tax Margin (Trailing 12 Months) | 29.81% |
Net Margin (Trailing 12 Months) | 23.56% |
Return on Equity (Trailing 12 Months) | 22.45% |
Return on Assets (Trailing 12 Months) | 19.22% |
Current Ratio (Most Recent Fiscal Quarter) | 6.73 |
Quick Ratio (Most Recent Fiscal Quarter) | 5.90 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 3.57 |
Book Value per Share (Most Recent Fiscal Quarter) | $2.49 |
Earnings per Share (Most Recent Fiscal Quarter) | -- |
Earnings per Share (Most Recent Fiscal Year) | -- |
Diluted Earnings per Share (Trailing 12 Months) | $0.56 |
Exchange | NASDAQ |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
Common Shares Outstanding | 4.59M |
Free Float | 3.26M |
Market Capitalization | $36.89M |
Average Volume (Last 20 Days) | 5085.15 |
Beta (Past 60 Months) | 0.94 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 29.00% |
Percentage Held By Institutions (Latest 13F Reports) | 23.16% |
Annual Dividend (Based on Last Quarter) | $0.50 |
Dividend Yield (Based on Last Quarter) | 6.23% |